TransMedics Reports First Quarter 2021 Financial Results

Go back to TransMedics Reports First Quarter 2021 Financial Results

TransMedics Group (TMDX) Reports In-Line Q1 EPS

May 4, 2021 5:13 PM EDT

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $7.05 million versus the consensus estimate of $7.1 million.

Recent Highlights

Net revenue of $7.1 million in the first quarter of 2021, representing a 6%... More